Bharat Petroleum Corporation Limited (BPCL) reported a 37% increase in net profit for the third quarter of FY2025, reaching ₹3,806 crore, although this figure fell short of market expectations. The company's revenue was recorded at ₹1.13 lakh crore. BPCL also declared an interim dividend of ₹5 per share. In contrast, Dr. Reddy's Laboratories experienced a 2.5% rise in net profit to ₹1,413.3 crore, with revenue growing 15.9% to ₹8,358.6 crore. However, the results did not meet analyst expectations, leading to a 6.2% drop in share price to ₹1,209.70. Additionally, Hindustan Petroleum Corporation (HPCL) reported a substantial 378.9% increase in net profit to ₹3,022.9 crore, with revenue rising 10.6% to ₹1,10,505.4 crore. The market is closely monitoring these earnings as companies continue to report their Q3 results for FY2025.